Panuveitis clinical trials
The registry lists 34 studies for Panuveitis across more than 10 countries. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-17.
Status
- Completed
- 23
- Withdrawn
- 3
- Status unknown
- 3
- Terminated
- 2
- Active, not recruiting
- 1
- Recruiting
- 1
Phase
- Phase 2
- 10
- Phase 3
- 10
- Phase 1
- 6
- Phase 4
- 4
Where
- United States
- 20
- Germany
- 6
- India
- 6
- Austria
- 5
- France
- 5
- United Kingdom
- 5
Who runs them
AbbVie (5) · Clearside Biomedical, Inc. (5) · Lux Biosciences, Inc. (3) · Novartis Pharmaceuticals (2) · Sirion Therapeutics, Inc. (2) · Mallinckrodt (1) · Glenn Jaffe (1) · University Hospital Tuebingen (1)
Studies
Recruiting first, then most recently updated. Showing 34 of 34 — search for more.
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept StudyRecruitingNCT06085079Phase 41 country
- Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiSNot yet recruitingNCT05928754Not applicable
- A Study of REGN7041 for Active Noninfectious Uveitis in Adult ParticipantsTerminatedNCT07218770Phase 1/21 country
- A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisCompletedNCT05414201Phase 41 country
- Ozurdex Monotherapy TrialWithdrawnNCT05101928Phase 41 country
- Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisActive, not recruitingNCT05384249Phase 27 countries
- Ocular Sarcoidosis Open Label Trial of ACTHAR GelCompletedNCT02725177Not applicable1 country
- Intravitreal Sirolimus as Therapeutic Approach to UveitisWithdrawnNCT01280669Phase 21 country
- Evaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or PanuveitisCompletedNCT03308045Phase 1/22 countries
- HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitisCompletedNCT029160171 country
- Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)TerminatedNCT03656692Phase 41 country
- Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis PatientsCompletedNCT033391021 country
- A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisCompletedNCT01148225Phase 3
- Suprachoroidal Injection of CLS-TA in Patients With Non-infectious UveitisCompletedNCT03097315Phase 31 country
- MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301CompletedNCT029520012 countries
- Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisCompletedNCT02595398Phase 33 countries
- Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat UveitisCompletedNCT01789320Phase 1/21 country
- Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeCompletedNCT0315524312 countries
- Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious UveitisCompletedNCT02255032Phase 21 country
- Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,CompletedNCT01526889Phase 22 countries
- Safety, Tolerability, and Efficacy of AEB071 in the Treatment of UveitisCompletedNCT00615693Phase 21 country
- Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior UveitisCompletedNCT02746991Phase 31 country
- Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or PanuveitisCompletedNCT01781936Phase 11 country
- Pilot Project: The Amplicon and Metatranscriptomic Study of Intra and Extra Intestinal Microbiome in Non-infectious Uveitis DiseaseStatus unknownNCT041268501 country
- Sirolimus as Therapeutic Approach to UveitisCompletedNCT00908466Phase 11 country
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 31 country
- Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS StudyStatus unknownNCT01717170Phase 1/21 country
- Study of FTY720 in Patients With UveitisWithdrawnNCT01791192Phase 2
- A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisCompletedNCT00404612Phase 37 countries
- A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior UveitisCompletedNCT00404885Phase 37 countries
- A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisCompletedNCT00404742Phase 37 countries
- Quality of Life and Visual Function in Uveitis PatientsStatus unknownNCT004073161 country
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe UveitisCompletedNCT00407056Phase 3
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of UveitisCompletedNCT00406887Phase 3